As of 2025-11-02, the Fair Value of Shield Therapeutics PLC (STX.L) is -8.64 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.65 GBP, the upside of Shield Therapeutics PLC is -229.89%.
With the market price of 6.65 GBP and our fair value calculation, Shield Therapeutics PLC (STX.L) is not a good investment. Investing in STX.L stocks now will result in a potential loss of 229.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -2.63 | -19.68 | -49.79 | -33.29 | -27.18 | -26.51 |
| YoY growth | 70.11% | -648.21% | -153.02% | 33.13% | 18.36% | -135.93% |
| Market Cap (mil) | 81.76 |
| P/E | |
| Forward P/E |
| EPS | -1.73 |
| Avg earnings growth rate | -135.93% |
| TTM earnings | -21.24 |